2 assets in Acid Sphingomyelinase Deficiency

Therapeutic assets addressing Acid Sphingomyelinase Deficiency, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cald Hr-D Acid Sphingomyelinase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Recombinant Human Acid Sphingomyelinase Acid Sphingomyelinase Deficiency	Sanofi	P2	NR ()